Assessment of lymphopenia in patients with multiple sclerosis treated with dimethyl fumarate in a real clinical setting

被引：0
|
作者：
Alroughani, Raed [1 ]
Ahmed, Samar [2 ]
Behbehani, Raed [2 ]
Al-hashel, Jasem [3 ]
机构：
[1] Amiri Hosp, Kuwait, Kuwait
[2] Ibn Sina Hosp, Kuwait, Kuwait
[3] Kuwait Univ, Kuwait, Kuwait
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
47
引用
收藏
页码：NP18 / NP18
页数：1
相关论文
共 50 条
  • [41] Lymphopenia in Multiple Sclerosis Patients Treated with Delayed-Release Dimethyl Fumarate: Analysis of 2 Electronic Health Record Databases in the US
    Wenten, Made
    Everage, Nicholas
    Somani, Teesta
    Lally, Cathy
    Juneja, Maneesh
    Eaton, Susan
    Prada, Claudia
    Dilley, Anne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 449 - 450
  • [42] COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis
    Mantero, Vittorio
    Abate, Lucia
    Basilico, Paola
    Balgera, Roberto
    Salmaggi, Andrea
    Nourbakhsh, Bardia
    Cordano, Christian
    JOURNAL OF NEUROLOGY, 2021, 268 (06) : 2023 - 2025
  • [43] Progressive multifocal leukoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate
    Lyons, Jennifer
    Hughes, Richard
    McCarthy, Kerry
    Everage, Nicholas
    Kapadia, Shivani
    Miller, Catherine
    Singhal, Priya
    Smirnakis, Karen
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2022, 8 (04)
  • [44] Haematological abnormalities in a series of patients with multiple sclerosis treated with teriflunomide or dimethyl fumarate
    Garcia-Estevez, D. A.
    Sabbagh, N.
    Perez Lorenzo, G.
    Pardo Parrado, M.
    Lopez Diaz, L. M.
    Cid Rodriguez, C.
    Ozaita Arteche, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 915 - 915
  • [45] Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients
    Jordan, Allison L. M.
    Yang, Jennifer
    Fisher, Caitlyn J.
    Racke, Michael K.
    Mao-Draayer, Yang
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (01) : 7 - 15
  • [46] Safety and efficacy of dimethyl fumarate in patients with multiple sclerosis - real world experience
    Chaves, C.
    Ganguly, R.
    Dionne, C.
    Camac, A.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 202 - 202
  • [47] Persisting lymphopenia and dimethyl fumarate: A clinical commentary
    Diem, Lara
    Chan, Andrew
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (08) : 1309 - 1310
  • [48] Dimethyl fumarate associated lymphopenia in clinical practice
    Longbrake, Erin E.
    Cross, Anne H.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 796 - 797
  • [49] Lymphopenia with dimethyl fumarate and fingolimod in clinical practice
    Hersh, C. M.
    Cohn, S.
    Hara-Cleaver, C.
    Bermel, R. A.
    Fox, R. J.
    Cohen, J. A.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 349 - 350
  • [50] Factors associated with dimethyl fumarate use and treatment patterns among patients with multiple sclerosis in a real-world setting
    Iyer, R.
    Sussman, M.
    Fay, M.
    Buckley, B.
    Lee, A.
    Sarda, S.
    Rana, J.
    Menzin, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E316 - E316
12345